UNLABELLED: Spinal cord injury (SCI) causes rapid and marked bone loss. The present study demonstrates that low-intensity vibration (LIV) improves selected biomarkers of bone turnover and gene expression and reduces osteoclastogenesis, suggesting that LIV may be expected to benefit to bone mass, resorption, and formation after SCI. INTRODUCTION: Sublesional bone is rapidly and extensively lost following spinal cord injury (SCI). Low-intensity vibration (LIV) has been suggested to reduce loss of bone in children with disabilities and osteoporotic women, but its efficacy in SCI-related bone loss has not been tested. The purpose of this study was to characterize effects of LIV on bone and bone cells in an animal model of SCI. METHODS: The effects of LIV initiated 28 days after SCI and provided for 15 min twice daily 5 days each week for 35 days were examined in female rats with moderate severity contusion injury of the mid-thoracic spinal cord. RESULTS: Bone mineral density (BMD) of the distal femur and proximal tibia declined by 5 % and was not altered by LIV. Serum osteocalcin was reduced after SCI by 20 % and was increased by LIV to a level similar to that of control animals. The osteoclastogenic potential of bone marrow precursors was increased after SCI by twofold and associated with 30 % elevation in serum CTX. LIV reduced the osteoclastogenic potential of marrow precursors by 70 % but did not alter serum CTX. LIV completely reversed the twofold elevation in messenger RNA (mRNA) levels for SOST and the 40 % reduction in Runx2 mRNA in bone marrow stromal cells resulting from SCI. CONCLUSION: The findings demonstrate an ability of LIV to improve selected biomarkers of bone turnover and gene expression and to reduce osteoclastogenesis. The study indicates a possibility that LIV initiated earlier after SCI and/or continued for a longer duration would increase bone mass.
UNLABELLED: Spinal cord injury (SCI) causes rapid and marked bone loss. The present study demonstrates that low-intensity vibration (LIV) improves selected biomarkers of bone turnover and gene expression and reduces osteoclastogenesis, suggesting that LIV may be expected to benefit to bone mass, resorption, and formation after SCI. INTRODUCTION: Sublesional bone is rapidly and extensively lost following spinal cord injury (SCI). Low-intensity vibration (LIV) has been suggested to reduce loss of bone in children with disabilities and osteoporoticwomen, but its efficacy in SCI-related bone loss has not been tested. The purpose of this study was to characterize effects of LIV on bone and bone cells in an animal model of SCI. METHODS: The effects of LIV initiated 28 days after SCI and provided for 15 min twice daily 5 days each week for 35 days were examined in female rats with moderate severity contusion injury of the mid-thoracic spinal cord. RESULTS: Bone mineral density (BMD) of the distal femur and proximal tibia declined by 5 % and was not altered by LIV. Serum osteocalcin was reduced after SCI by 20 % and was increased by LIV to a level similar to that of control animals. The osteoclastogenic potential of bone marrow precursors was increased after SCI by twofold and associated with 30 % elevation in serum CTX. LIV reduced the osteoclastogenic potential of marrow precursors by 70 % but did not alter serum CTX. LIV completely reversed the twofold elevation in messenger RNA (mRNA) levels for SOST and the 40 % reduction in Runx2 mRNA in bone marrow stromal cells resulting from SCI. CONCLUSION: The findings demonstrate an ability of LIV to improve selected biomarkers of bone turnover and gene expression and to reduce osteoclastogenesis. The study indicates a possibility that LIV initiated earlier after SCI and/or continued for a longer duration would increase bone mass.
Authors: Liqin Xie; Jeffrey M Jacobson; Edna S Choi; Bhavin Busa; Leah Rae Donahue; Lisa M Miller; Clinton T Rubin; Stefan Judex Journal: Bone Date: 2006-07-07 Impact factor: 4.398
Authors: M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan Journal: Am J Hum Genet Date: 2001-02-09 Impact factor: 11.025
Authors: Alfredo Arija-Blázquez; Silvia Ceruelo-Abajo; María S Díaz-Merino; Juan Antonio Godino-Durán; Luís Martínez-Dhier; José Florensa-Vila Journal: Eur J Appl Physiol Date: 2012-05-11 Impact factor: 3.078
Authors: W Qin; W Zhao; X Li; Y Peng; L M Harlow; J Li; Y Qin; J Pan; Y Wu; L Ran; H Z Ke; C P Cardozo; W A Bauman Journal: Osteoporos Int Date: 2016-07-20 Impact factor: 4.507
Authors: Wei Zhao; Yuanzhen Peng; Yizhong Hu; X Edward Guo; Jiliang Li; Jay Cao; Jiangping Pan; Jian Q Feng; Christopher Cardozo; Jonathan Jarvis; William A Bauman; Weiping Qin Journal: Bone Date: 2020-12-19 Impact factor: 4.398
Authors: A Schwarz; C Pick; R Harrach; G Stein; H Bendella; O Ozsoy; U Ozsoy; E Schoenau; P Jaminet; L Sarikcioglu; S Dunlop; D N Angelov Journal: J Musculoskelet Neuronal Interact Date: 2015-06 Impact factor: 2.041
Authors: Ami P Raval; Marc Schatz; Pallab Bhattacharya; Nathan d'Adesky; Tatjana Rundek; W Dalton Dietrich; Helen M Bramlett Journal: Int J Mol Sci Date: 2018-09-13 Impact factor: 5.923
Authors: Yuanzhen Peng; Wei Zhao; Yizhong Hu; X Edward Guo; Jun Wang; Ke Hao; Zhiming He; Carlos Toro; William A Bauman; Weiping Qin Journal: Neurotrauma Rep Date: 2021-12-08
Authors: Melissa Ann Huberman; Nathan D d'Adesky; Qismat Bahar Niazi; Miguel A Perez-Pinzon; Helen M Bramlett; Ami P Raval Journal: Neuromolecular Med Date: 2021-07-03 Impact factor: 3.843